Allogeneic hematopoietic stem cell transplantation: complications and results.
about
Non-Hematopoietic Essential Functions of Bone Marrow Cells: A Review of Scientific and Clinical Literature and Rationale for Treating Bone DefectsMesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challengesChimerism of metanephric adenoma but not of carcinoma in kidney transplants.Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.An individualized dyadic problem-solving education intervention for patients and family caregivers during allogeneic hematopoietic stem cell transplantation: a feasibility study.The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).The relationship of health behaviors with sleep and fatigue in transplant caregivers.Structural investigation of donor age effect on human bone marrow mesenchymal stem cells: FTIR spectroscopy and imaging.Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.Stem cells in clinical practice: applications and warnings.Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysisHematopoietic stem cell transplantation nursing: a practice variation study.Cerebral salt-wasting syndrome after hematopoietic stem cell transplantation in adolescents: 3 case reportsIncreasing hematopoietic stem cell yield to develop mice with human immune systems.CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction.Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation.Psychopathological Aspects in Childhood Hematopoietic Stem Cell Transplantation (HSCT): The Perception of Parents and AdolescentsClinical applications of mesenchymal stem cellsStem cell therapy in autoimmune rheumatic diseases: a comprehensive review.Clinical Trials With Mesenchymal Stem Cells: An Update.Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research.Bone marrow-derived mesenchymal stem cells up-regulate acetylcholine receptor delta subunit through NRG/ErbB3-mediated mitogen-activated protein kinase pathway.Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood.Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation.Isolation and therapeutic potential of human haemopoietic stem cells.Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels.Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients.Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy.A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation.Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.Mesenchymal Stem Cell Transplantation for Tissue Repair.
P2860
Q26770338-171526C8-4246-46DA-85F1-B98B1F165CBBQ30009860-F600BC44-4608-4ECA-8F44-04B0E35555FDQ33209554-50C9EF82-9B4A-4E98-847A-F9D32265E58CQ33722466-862DB6A7-6576-4607-8DA4-2D0B4B62AE35Q33775787-3A2636B3-BF7A-4E8B-8C8E-837858F16D4DQ33914006-68EAE37C-3591-48BA-A626-9708B6139C60Q33926369-8AD056E6-AD91-44DB-8CFA-FBE50AF49946Q34116100-0A008968-E4DA-4F6B-924B-38519487CBC7Q34294935-3A9E9388-9010-4A51-BFED-AFC695332A2CQ34552765-2EF630B4-F45D-47A5-BAFA-FE62CD0345A3Q35223500-30632ABF-7522-454D-B8AD-82F97BEE6974Q35758593-8C9C2551-807A-4B6F-A229-AF41BB3CBE02Q35994849-753DF2E7-52F2-437C-9403-B0F87C64A1D3Q36282887-5725E955-6696-4B13-A4EC-713331894A67Q36488589-64D6C043-431D-4516-A4E2-8FEDA0B5797CQ36651190-D15FEEC2-347A-47E6-BC76-974F0E01C2F2Q36653215-4CE8AD44-8563-445E-BB31-A30C331C41DBQ37150434-122023D8-8E0D-41D0-938A-96B049786DCBQ37200061-9CD92B7B-328C-433A-85E8-51E8B2FDC22DQ37208341-F641C1C2-4751-4338-9A3B-ECD3CC14F4BCQ37426583-BC202D28-0333-4D0B-B72E-9539731C5DF4Q37737592-B4C36E81-2EB8-4479-BF76-837F392B59AFQ38122364-5D638827-A786-41BD-B6BC-B8E35CD02DC7Q38242079-F82FE05F-7873-4D83-BEBC-824EA0D2424FQ38596084-82814F1F-2DF2-4468-86F2-F5E8BCFEABC8Q38837844-B3F4CF17-44BD-40B8-B4C5-FF70ED84BB07Q39388270-48482556-12F6-40A4-A2B9-91FBD1125D40Q40132477-5E332960-BBC5-4E98-97AE-8960C76E3C97Q40429162-18A855B6-D294-4A6C-B6E3-3B9B638B9BBAQ41652393-542708BD-18F0-4007-8C17-A83F6A633F24Q41787137-284B9A67-F478-4108-AC27-E0CE79F8C316Q42716642-193E0DEF-F339-4F5B-ADF2-3EAF05A63538Q44453411-00A9465C-94BF-47B6-9EF7-C2A8F2989691Q44578369-BFD76E25-2929-4D7F-9EB0-0CA1B12A422CQ46121892-BF416962-7382-4BEC-9E52-5EFFFE8D77E4Q46440763-788B356D-2F86-4220-B98C-043407896950Q47222758-5814D9A4-0B42-426E-A064-FE73C0591F9BQ51152596-F7A1EED8-66F5-4AF2-871F-81482D06FFE6Q52747221-C3B34E3B-33EF-41A9-B65C-D1084463480BQ55314890-26239F2E-09A1-4778-9989-24280FC070A7
P2860
Allogeneic hematopoietic stem cell transplantation: complications and results.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Allogeneic hematopoietic stem cell transplantation: complications and results.
@ast
Allogeneic hematopoietic stem cell transplantation: complications and results.
@en
type
label
Allogeneic hematopoietic stem cell transplantation: complications and results.
@ast
Allogeneic hematopoietic stem cell transplantation: complications and results.
@en
prefLabel
Allogeneic hematopoietic stem cell transplantation: complications and results.
@ast
Allogeneic hematopoietic stem cell transplantation: complications and results.
@en
P2093
P1476
Allogeneic hematopoietic stem cell transplantation: complications and results.
@en
P2093
Connie Morgan
Imad A Tabbara
Kathy Zimmerman
Zeina Nahleh
P304
P356
10.1001/ARCHINTE.162.14.1558
P407
P577
2002-07-01T00:00:00Z